Cravath represented Lazard Group LLC in connection with its US$400 million registered senior debt offering. Lazard is one of the world’s preeminent financial advisory and asset management firms. The transaction closed on February 13, 2015. More >>
Tags: New York
Buchalter Nemer Welcomes Michael Caspino
Buchalter Nemer is pleased to announce the addition of Michael Caspino. Mr. Caspino joins the Firm as a Shareholder in the Firm’s Litigation Practice Group in Orange County. A practicing attorney for more than twenty years, Mr. Caspino has successfully taken cases to trial in areas of law that include wrongful death, product liability, construction defects, employment, environmental claims and business disputes. More >>
Tags: Buchalter PC | Orange County
Milbank Adds Global Securities Partner David Kuo in Hong Kong
In a significant addition to its longstanding Asia and Hong Kong securities practice, Milbank, Tweed, Hadley & McCloy LLP announced that corporate and capital markets adviser David Kuo has joined the firm as a partner in its Hong Kong office.
Mr. Kuo represents Chinese companies and other high-yield issuers and underwriters on a wide variety of debt- and equity-linked capital markets transactions—including high-yield, investment-grade, RMB, convertibles and corporate hybrids. He also counsels on liability management exercises, including debt restructuring, tender offers and exchange offers. More >>
Tags: Milbank LLP | Hong Kong
Shearman & Sterling Advises on Financing in Acquisition of Glimcher Realty Trust by Washington Prime Group
Shearman & Sterling represented Citigroup Global Markets, Inc., as lead arranger and administrative agent, in connection with the $1.19 billion bridge financing of the $4.3 billion acquisition by Washington Prime Group Inc. of Glimcher Realty Trust. More >>
Tags: Shearman & Sterling LLP | New York
Kirkland & Ellis Advises EMR Capital on Closing of US$450 Million EMR Capital Resources Fund 1
Kirkland & Ellis has advised EMR Capital, a specialist mining private equity manager, which recently closed EMR Capital Resources Fund 1. The fund was oversubscribed and closed with aggregate capital commitments of US$450 million. The fund, which will make investments in global metals and mining companies and projects, accepted commitments from a broad mix of global institutional investors, including endowments, foundations, family offices and fund of funds. More >>
Tags: Kirkland & Ellis LLP | London | New York
Brown Rudnick Adds Two Partners to its Global White Collar Practice
Brown Rudnick LLP, an international Am Law 200 law firm with offices in the US and Europe, announced today that former federal prosecutor Alex Lipman and Ashley L. Baynham have joined the firm as partners in the White Collar Defense & Government Investigations group in the New York office. Both were formerly partners at Nixon Peabody. More >>
Tags: Brown Rudnick LLP | New York
Gunster hires shareholder to private wealth services practice in Miami
Gunster, one of Florida’s oldest and largest full-service business law firms, is pleased to announce Mary Karr has joined the firm as a shareholder in the Miami office.
Karr is a member of Gunster’s private wealth services practice and has experience in estate planning internationally and domestically, in probate and trust administration, litigation and tax controversy. More >>
Tags: Gunster, Yoakley & Stewart, P.A. | MiamiMicrosoft Completes $10.75 Billion Debt Offering
Hess Corporation’s $4 Billion Credit Facility
Cravath represented the agent, JPMorgan Chase Bank, N.A., in connection with the arrangement of a $4 billion five‑year revolving credit facility for Hess Corporation, a leading independent energy company engaged in the exploration and production of crude oil and natural gas with operations in more than a dozen countries. The transaction closed on January 21, 2015. More >>
Tags: Cravath, Swaine & Moore LLP | New York
Goodwin Advises Voyager Therapeutics in up to $875 Million Strategic Collaboration with Genzyme
Goodwin Procter advised Voyager Therapeutics on its recently announced major strategic collaboration with Genzyme to discover, develop and commercialize novel gene therapies for severe central nervous system (CNS) disorders. According to the agreement, Genzyme will make an upfront commitment of $100 million to Voyager, including $65 million in cash, a $30 million equity investment in Voyager and additional in-kind contributions. Voyager is eligible to receive future potential development and sales milestone payments of up to $745 million, as well as tiered royalties on product sales. More >>
Tags: Goodwin Procter LLP | Boston